➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: January 22, 2021

DrugPatentWatch Database Preview

Details for Patent: 6,372,760

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,372,760
Title: Stabilized composition comprising antidementia medicament
Abstract:The present invention provides a stable composition of an antidementia medicament. Specifically, it is a stabilized composition of an antidementia medicament comprising an antidementia medicament and an organic acid. As the organic acid, tosyllic acid, mesyllic acid, benzoic acid, salicylic acid, tartaric acid, citric acid and the like are particularly preferable.
Inventor(s): Kato; Akira (Ibaraki, JP), Harada; Tsutomu (Aichi, JP), Murahashi; Naokazu (Aichi, JP), Sugaya; Yukiko (Ibaraki, JP), Ando; Hidenobu (Gunma, JP)
Assignee: Eisai Co., Ltd. (Tokyo, JP)
Application Number:09/700,342
Patent Claim Types:
see list of patent claims
Composition; Use;

Drugs Protected by US Patent 6,372,760

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,372,760

PCT Information
PCT FiledMarch 31, 1999PCT Application Number:PCT/JP99/01686
PCT Publication Date:October 12, 2000PCT Publication Number: WO00/59544

International Family Members for US Patent 6,372,760

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 254928   Start Trial
Germany 69913138   Start Trial
Denmark 1086706   Start Trial
European Patent Office 1086706   Start Trial
Spain 2211056   Start Trial
Portugal 1086706   Start Trial
World Intellectual Property Organization (WIPO) 0059544   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.